Title: Introduction to Human CD197/CCR7 HEK293T Stable Cell Line
The Human CD197/CCR7 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human chemokine receptor CD197, also known as CCR7. This stable cell line is derived from the human embryonic kidney cell line HEK293T, which has been transfected with the gene encoding for CD197. This cell line is an essential resource for researchers studying the role of CD197 in various biological processes, including immune cell migration and cancer metastasis.
Structure of Human CD197/CCR7
CD197 is a G-protein coupled receptor that is primarily expressed on the surface of immune cells, including T cells, B cells, and dendritic cells. It plays a crucial role in the homing and migration of these cells to secondary lymphoid organs. The Human CD197/CCR7 HEK293T Stable Cell Line expresses the full-length human CD197 protein, allowing for the study of its structure and function.
Activity of Human CD197/CCR7
The activity of CD197 is regulated by two chemokines, CCL19 and CCL21, which bind to the receptor and activate downstream signaling pathways. The Human CD197/CCR7 HEK293T Stable Cell Line can be used to study the binding affinity and signaling pathways of these chemokines. Additionally, this cell line can be used to investigate the effects of various ligands and inhibitors on CD197 activity, providing valuable insights into the regulation of this receptor.
Application of Human CD197/CCR7 HEK293T Stable Cell Line
The Human CD197/CCR7 HEK293T Stable Cell Line has various applications in both basic and clinical research. One of the primary uses of this cell line is in the field of immunology, where it can be used to study the role of CD197 in immune cell migration and trafficking. It has also been used to investigate the role of CD197 in various diseases, including cancer and autoimmune disorders.
One of the most exciting applications of the Human CD197/CCR7 HEK293T Stable Cell Line is in the development of novel therapeutics. CD197 has been identified as a potential therapeutic target for various diseases, and the use of this stable cell line can aid in the discovery and development of new drugs that target this receptor. The cell line can be used to screen potential compounds for their ability to bind to CD197 and modulate its activity, providing a valuable tool for drug discovery.
Flow Cytometry Analysis
Flow cytometry is a powerful technique used to analyze and quantify the expression of cell surface markers, including CD197. The Human CD197/CCR7 HEK293T Stable Cell Line can be easily analyzed using flow cytometry, allowing for the accurate measurement of CD197 expression levels. This is especially useful in drug discovery studies, where the effects of potential compounds on CD197 expression can be evaluated.
In conclusion, the Human CD197/CCR7 HEK293T Stable Cell Line is a valuable tool for studying the structure, activity, and application of the human chemokine receptor CD197. Its applications in immunology, drug discovery, and flow cytometry make it an essential resource for researchers interested in understanding the role of CD197 in various biological processes. With its stable and consistent expression of CD197, this cell line provides a reliable model for studying this important receptor.
There are no reviews yet.